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 6 
ABSTRACT 7 
Purpose Mobile bearing (MB) knee prostheses were designed to improve the performances of the 8 
total knee arthroplasties (TKA). The clinical superiority of MB prosthesis compared to its fixed 9 
bearing counterpart has remained elusive. This study prospectively evaluates the cumulative 10 
survivorship, clinical, radiographic results, and complications of a large series of MB TKAs in 11 
relation to patient age, sex, severity of arthritis, and patellar resurfacing.  12 
Methods This study evaluates the 5- to 10-year cumulative survival rate of the NexGen_ LPS MB. 13 
Between 2000 and 2005, we performed a consecutive series of 332 MB, posterior-stabilized TKA in 14 
249 patients (mean age 71.2 years, SD 6.9). The implants were clinically evaluated with the 15 
Hospital Special Surgery Knee Score (HSS-KS) and radiographically with the Knee Society 16 
Roentgenographic Evaluation System (KS-RES). The mean follow-up was 76.3 months (minimum 17 
5 years).  18 
Results The HSS-KS improved from 55 pre-operatively to 86 at the end of follow-up. According to 19 
the KS-RES, the implants were anatomically aligned and progressive radiolucent lines appeared in 20 
four knees (1.2 %). The patella was selectively resurfaced in 162 of 332 knees. Patients with the 21 
patella resurfaced had better clinical results compared to those not resurfaced, but there was no 22 
difference in terms of survival. The cumulative survival rate was 98.4 % at 10 years (Kaplan–23 
Meier’s analysis). 24 
Conclusions This MB implant provided reliable and durable clinical results with a survivorship of 25 
over 98 % at 10 years, in unselected patients regardless of age, sex, severity of disease, and patellar 26 
treatment. 27 
Level of evidence Therapeutic study, retrospective study (data collected prospectively), case series 28 
with no comparison group, Level IV. 29 
 30 
INTRODUCTION 31 
Total knee arthroplasty (TKA) has been shown to be effective, reliable [13, 22], and durable at 32 
relieving pain and improving function in patients with end-stage arthritis of the knee with 33 
survivorships ranging from 90 to 98 % at 10- to 15-year follow-up [5, 7–9, 15]. Mobile bearing 34 
(MB) knee prosthesis was designed and developed with the aim to provide a more physiological 35 
range of movement, to reduce the stress transfer at the bone–implant (cement) interface, and to 36 
reduce the stress on the tibial polyethylene insert, thus reducing wear [2, 28]. However, despite the 37 
theoretical advantages of a MB TKA, a significant difference in outcomes and longevity between 38 
fixed and MB knee prosthesis has not been reported [3, 12, 14, 17, 23].  39 
Furthermore, there are few studies reporting long-term results and complications associated with the 40 
use of MB TKAs [27]. Finally, the question remains: Who is this technology best suited for? While 41 
the theoretical wear characteristics of MBs are appealing for use in the younger and more active 42 
population, concerns with bearing instability and other complications may require further definition 43 
of the ideal population best suited for this technology. 44 
Therefore, the purpose of this study is to prospectively evaluate the cumulative survivorship, 45 
clinical, radiographic results, and complications of a large series of MB TKAs performed 46 
consecutively in non-selected patients using the Zimmer NexGen Legacy LPS mobile prosthesis 47 
(Zimmer, Warsaw IN). We compared these results in relation to patient age, sex, severity of 48 
arthritis, and patellar resurfacing. 49 
We hypothesized that the NexGen Legacy LPS mobile TKA can achieve reliable and durable 50 
results in all patients regardless of age, sex, arthritis severity, and patellar resurfacing. 51 
 52 
 53 
MATERIALS AND METHODS 54 
Between 2000 and 2005, 332 NexGen Legacy LPS MB knees (Zimmer, Warsaw IN) were 55 
implanted in 249 consecutive, unselected patients at our institution. There were 197 women (79.1 56 
%) and 52 men (20.9 %) with a mean age of 71.2 years (SD 6.9). The pre-operative diagnosis 57 
was osteoarthritis in 300 knees, rheumatoid arthritis in (n = 10), osteonecrosis of the medial femoral 58 
condyle (n = 18), and a failed unicompartmental knee arthroplasty (UKA) in four patients. 59 
All knees were performed under tourniquet using a standard medial parapatellar approach. The 60 
osteophytes were removed, and the distal femoral resection was set at 5 degrees of valgus. The tibia 61 
was cut perpendicular to its axis, and ligament balancing was performed aimed to achieve a 62 
balanced flexion and extension gap and restoration of the anatomical axis of the limb. The patella 63 
was selectively resurfaced in 163 knees, while was not in 169 knees. The patella was resurfaced 64 
only in cases of severe articular cartilage degeneration, significant deformity, and maltracking. In 65 
all cases, the patella was treated with thermal denervation with electrocautery. Following trialing, 66 
all components were cemented into place. Following surgery, early patient mobilization was 67 
encouraged and received low molecular weight heparin (LMWH) for deep venous thrombosis 68 
prophylaxis. 69 
Post-operatively, patients were evaluated at regularly scheduled intervals (3 weeks, 3, 6, 12 months, 70 
and annually thereafter). The patients who were unable to be evaluated in person were monitored 71 
using a validated telephone questionnaire [19]. The clinical outcome was evaluated using the 72 
Hospital for Special Surgery Knee Score (HSS-KS) [24]. The patellofemoral joint was evaluated 73 
for patellar mobility (absent, normal, hypermobile), anterior knee pain (absent, at rest, standing), 74 
and for the presence of patellofemoral crepitus (present or absent).  75 
Radiographic outcome was evaluated using the Knee Society Roentgenographic Evaluation System 76 
(KS-RES) [10]. Serial radiographs were used to evaluate alignment, progressive radiolucent lines, 77 
osteolysis, and prosthesis loosening. Radiolucent lines were defined as progressive when greater 78 
than 2 mm and in cases if changes in at least two serial radiographs. Finally, each patient was asked 79 
to report on the subjective outcome of the procedures by comparing their TKA to their pre-80 
operative knee (1—no pain, 2—mild or moderate pain, 3—painful, and 4—as painful as prior to 81 
surgery) and to report their degree of satisfaction with the procedure (1—very satisfied, 2—82 
satisfied, 3—not satisfied, and 4—very disappointed) [29]. 83 
All persons gave informed consent prior to their inclusion in the study, which has been performed 84 
in accordance with the ethical standards as certified by the protocol 0008016 from the Institution 85 
Citta` della Salute e della Scienza di Torino. 86 
 87 
Statistical analysis.  88 
The cumulative survivorship of the implant was determined using the Kaplan–Meier method. 89 
Failure was defined as revision of the implant for any reason. The clinical outcomes between 90 
patients who had a resurfaced patella compared to those who did not were compared using the 91 
Mann–Whitney test. A regression model was used to assess the relationship between pre-operative 92 
and post-operative knee scores. Because this analysis was performed at the ‘‘knee-level’’, the 93 
Huber–White estimator was used to adjust for correlation between observations contributed by the 94 
same patient. The nonlinear effects of covariates were modelled using a restrictive cubic-spline 95 
function, and their significance was assessed using the Chisquare test. The calculations were 96 
performed using R version 2.14 [25]. 97 
 98 
RESULTS 99 
The average follow-up was 76.3 months (range 60–122 months). Eight patients died (8 knees), and 100 
twenty patients (27 knees) were lost to follow-up. Of the remaining 221 patients (305 knees) (92 %) 101 
included in the final analysis, 208 patients (284 knees) had complete records and were subjected to 102 
clinical and radiographic evaluation, while thirteen patients (13 knees) were evaluated by phone 103 
survey.Clinically, the total HSS-KS significantly improved after surgery (p\0.001) as well as all 104 
clinical parameters improved from the pre-operative evaluation to the final follow-up evaluation 105 
(Table 1). There were no significant differences in the HSS-KS between men and women and 106 
among patients who were older than 68 years compared to those younger than 68 years of age at the 107 
time of surgery (Table 2). Patients presenting higher scores prior to surgery end up with higher 108 
scores after surgery. However, there was a significant difference in the improvement (delta) of 109 
HSS-KS between patients with HSS-KS less than 50 points prior to surgery (207 patients: mean 110 
pre-op HSS-KS 43.2 ± SD 5.6; mean post-op HSS-KS 79.6 ± SD 8.6) compared to those with 111 
scores greater than 50 points (125 patients: mean pre-op HSS-KS 57.2 ± SD 4.4; mean postop HSS-112 
KS 87.8 ± SD 4.5) (p\0.01). Figure 1 reports the total knee score after arthroplasty as function of the 113 
preoperative score adjusted for age, sex, replaced patella, and pre-operative range of movement 114 
scores. Since this study reports on a single cohort of patients undergoing TKA, the clinical results 115 
throughout the entire study period are shown in Table 3. 116 
There were no significant differences between patients undergoing patellar resurfacing and patients 117 
with unresurfaced patellae in terms of HSS-KS scores (Table 4). Also, the two groups showed no 118 
differences in terms of patellar mobility (p = ns). On the contrary, the unresurfaced group presented 119 
higher percentage of anterior knee pain (p = 0.013) and patellar crepitus (p\0.001) compared to 120 
the resurfaced group (Table 5). 121 
Fifty-eight patients (68 knees, 26.2 %) were very satisfied with surgery, 124 patients (182 knees, 122 
56.1 %) were satisfied, twenty-six patients (34 knees, 11.8 %) were not satisfied, and thirteen 123 
patients (13 knees, 5.9 %) were very disappointed. When questioned about pain in their TKA 124 
compared to pre-operatively, 159 patients (219 knees, 71.9 %) were not painful and had no activity 125 
limitations, forty patients (53 knees, 18.1 %) reported mild pain, fifteen patients (17 knees, 6.8 %) 126 
had moderate pain restricting certain activities, and seven patients (8 knees, 3.2 %) reported 127 
increased pain compared to their pre-operative knees. Despite these results, 214 of 221 patients 128 
surveyed (97 %) said that they would undergo TKA for their knee arthritis. 129 
The radiographic follow-up was 70 months (range 60–110). Serial radiographs from 284 knees (86 130 
%) were available for final analysis. Table 6 reports the detailed results of radiological findings: 131 
alignment and radiolucent lines. In this series, radiolucent lines were most commonly encountered 132 
in zone 6 on the tibial side on AP radiographs and zones 3 and 1 for the tibial and femoral 133 
components, respectively, on the lateral radiograph. There were no differences in HSS-KS, 134 
function, pain, stairs in patients with non-progressive radiolucent lines to patients without 135 
radiolucent lines (Table 7). Osteolysis without loosening was not observed.  136 
There were no cases of bearing instability or dislocation. At final follow-up, five of 332 TKA (1.5 137 
%) were revised. Three knees were revised for aseptic loosening and 2 knees failed secondary to 138 
infection. The Kaplan–Meier survivorship analysis using revision for any reason as an endpoint 139 
revealed a 98.4 % survivorship of this MB TKA design at 10 years. The 10-year cumulative 140 
survivorship rate for patient with resurfaced patellae compared to those with unresurfaced patellae 141 
was 99.3 and 97.5 %, respectively (n.s.). 142 
 143 
Discussion 144 
The most important finding was that this MB TKA design provided reliable pain relief and 145 
improved function in patients with end-stage arthritis of the knee regardless of age, sex, severity of 146 
arthritis, and patellar resurfacing. The cumulative survivorship of this particular implant with failure 147 
defined by revision surgery for any reason was more than 98 % at 10 years. There were no 148 
significant differences between male and female patients and between patients younger than age 68 149 
compared to those older than 68 of age. These results are consistent with other published results on 150 
MB knees [16, 18]. Argenson et al. reported on a series of 116 consecutive rotating platform PS 151 
TKA using the same knee design. At 10 years, the authors reported a survivorship of 98.3 % and 152 
observed similar improvements in Knee Society scores and range of motion. There were also no 153 
differences in outcomes with regard to age or sex [1]. Meftah et al. also reported good midterm 10-154 
year outcomes of MB PS knees using the Depuy LCS knee design (Depuy, Warsaw IN). In their 155 
series of 117 consecutive knees, 10-year survivorship due to mechanical failure was 100 and 97.7 % 156 
with revision at any end point [20]. Consequently, modern MB knee designs including the NexGen 157 
LPS mobile TKA can provide reliable and durable clinical results with low failure rates at midterm 158 
follow-up. 159 
In this study, there were no significant differences in HSS-KS, functional score, stair climbing, and 160 
range of motion between patients who underwent patellar resurfacing compared to those without 161 
patellar resurfacing. While there were no significant differences in patellar mobility between the 2 162 
groups, a higher percentage of patients without patellar resurfacing reported residual anterior knee 163 
pain at rest and patellar crepitus. The aetiology of these findings is unclear, but others also had 164 
similar results comparing groups of patients undergoing patellar resurfacing in TKA. A recent meta-165 
analysis showed no clinical differences between resurfaced and unresurfaced patellae, 166 
but also indicated that patellar resurfacing reduced the risk of reoperation for persistent pain after 167 
TKA [11]. However, other studies have also shown significant association between knee flexion 168 
contracture and anterior knee pain in knees with patellar resurfacing [26], thus supporting the 169 
importance of both surgical technique and the design. 170 
Nevertheless, the majority of the studies have demonstrated no clinical differences between 171 
resurfacing and nonresurfacing of the patella during TKA [4, 6]. In this series, the incidence of 172 
overall anterior knee pain was 4 % in the  patellar resurfacing group compared to 12 % in 173 
nonresurfaced group. While one of the advantages of MB TKA is the ‘‘self-centering’’ motion 174 
leading to improved patellar tracking, our results showed that the use of MBs did not eliminate 175 
anterior knee pain or patellofemoral complaints (such as crepitus). These findings are consistent 176 
with other reports showing no significant benefit of a MB knee to the patella–femoral articulation 177 
[21]. 178 
Radiographic analysis of MB TKA in this series revealed the presence of radiolucent lines in 22.5 179 
% of knees at a follow-up of more than 6 years, but only four knees had progressive radiolucencies. 180 
Non-progressive radiolucent lines were more commonly present below the medial and lateral edges 181 
of the tibial plateau in the AP view and behind the proximal flange of the femoral component in the 182 
lateral projection. Osteolysis was not observed patients with non-progressive radiolucent lines. 183 
Similar radiographic results of no malalignment, no spinout, no osteolysis, and occasional presence 184 
of non-progressive radiolucent lines have also been reported in a similar series with a different 185 
implant [20]. The aetiology of radiolucent lines is unknown but may be multifactorial including 186 
surgical technique. Argenson et al. also reported nearly 14 % (15/116) non-progressive radiolucent 187 
lines in their series of MB knees of the same design without compromise of their durability [1]. 188 
Consequently, while a significant number of knees had radiolucent lines, the low rate of progressive 189 
radiolucent lines (3 %) and lack of osteolysis point to favourable wear characteristics of this MB 190 
knee design.  191 
This study had several limitations. First, this is a retrospective review of our institutional experience 192 
using this MB knee implant. While the majority of these cases were performed by a single surgeon 193 
(MC), there were a few TKAs included for final analysis that was performed by others, potentially 194 
introducing surgical bias. However, this is a group of consecutive, unselected patients with 195 
prospectively collected data with high follow-up rate; thus minimizing the risk of recall bias. 196 
Second, there was a lack of a control or comparative group in this study. Therefore, this is simply a 197 
descriptive study, and no statements about superiority can be made with regard to this type of 198 
prosthesis over another. Third, the age of this cohort of patients in this study averaged more than 70 199 
years (range 21–89), and therefore, this can affect the final results as demonstrated by the 200 
decreasing total HSS-KS throughout the study period. An advantage of MBs is a theoretical 201 
potential reduction in wear. However, if the prosthesis is used in older patients, it may lead to 202 
overstatement of longevity due to lower functional demands and understatement of potential 203 
complications. Nevertheless, younger patients in this series had equivalent clinical outcomes and 204 
prosthesis survivorship compared to older patients in this group. Consequently, MB TKAs can be 205 
used safely and reliably in  patients of all ages and functional demands. Fourth, while the choice to 206 
resurface the patella during TKA was based on strict, criteria, the final decision can be modified by 207 
a surgeon’s preference and choice, thus introducing bias. This can potentially limit the comparisons 208 
of patellar resurfacing and non-resurfacing in this series. However, because the groups of patellar 209 
treatment had similar characteristics, it allows for some conclusions about the patella in MB TKA. 210 
Finally, while this is a relatively large consecutive series of MB TKAs utilizing a single knee 211 
design, an average followup of 76.3 months is not long enough to derive significant conclusions 212 
with respect to longevity and durability. 213 
However, this series represents a non-designing surgeon series with comparative outcomes and 214 
survivorships, thus validating the safety and effectiveness of this knee design with utility for 215 
surgeons’ decisions in terms of implant selection. 216 
 217 
Conclusion 218 
The studied MB knee prosthesis provided reliable and durable clinical results with a survivorship of 219 
over 98 % at 10 years, in unselected patients regardless of age, sex, severity of disease, and patellar 220 
treatment. Conflict of interest No benefits in any form have been received or will be received from a 221 
commercial party related directly or indirectly to the subject of this article. 222 
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 305 
Figure 1. Total knee score after arthroplasty as function of the preoperative score adjusted for age, 306 
sex, replaced patella, and preoperative range of movement scores 307 
 308 
 309 
310 
Table 1. HSS-KS results for all patients. The numbers reported are mean(SD). N is the number of 311 
non missing value for each variable. The Wilcoxon test for paired data was used. 312 
 313 
 
N Pre-operative Post-operative p-value 
Total Knee Score  305   54.6 (7.2)    86.3 (6.4)  <0.001 
  Range (28-66) Range (43-98)  
Pain score 305    7.33(2.5)    13.74 (2.2)  <0.001 
Functional score 304    6.41 (2.6)      10.9 (1.0)  <0.001 
Range of movement (ROM) 304   67.16 (8.8)  114.3  (16.5) <0.001 
Pre-operative ROM classes 
   
 
(55;60] 95 - 124.9 (18.9)  
(60;65] 47 - 100.6 (8.9)  
(70;75] 109 - 107.3(8.0)  
(75;80] 53 - 121.7 (14.4)  
Stairs 304    2.2 (0.7)    4.4 (1.2) <0.001 
 314 
 315 
 316 
 317 
318 
Table 2. Comparison of HSS-KS results by gender and age. The numbers reported are mean (SD). 319 
The Mann-Whitney test was used at p<0.05. 320 
                                Females                    Males                    
p-
value 
Age class: 55-68                Age >68                  p-
value  
                                 (N=261)              (N=71)               (N=88)               (N=244)              
Total Knee Score  86.4 (6.4) 85.7(6.22) ns 87.1 (5.8) 85.9 (6.5) ns 
Pain  12.3 (2.5) 12.1 (2.5) ns 12.3 (2.5) 12.3 (2.5) ns 
Pain at test 13.8 (2.14) 13.5 (2.3) ns 14.0 (2.0) 13.7 (2.2) ns 
Functional score 11.0 (1.0) 10.7 (1.0) ns 10.9 (1.0) 10.8 (1.0) ns 
Range of 
movement 114.4 (16.5) 113.8 (16.6) ns 113.3 (15.2) 114.6 (17.0) ns 
Stairs 4.4(1.2) 4.5(1.2) ns 4.3(1.2) 4.4(1.1) ns 
 321 
322 
Table 3. Total HSS-KS, pain, functional score, range of motion, and stairs data of all time points 323 
 324 
Time N 
Total knee 
score Pain 
Functional 
Score 
Range of montion 
(ROM) Stairs 
Pre-op 332 54.6(7.2) 7.3(2.5) 6.4(2.6) 67.2(8.8) 2.2(0.7) 
3 months 332 80.6(5.4) 12.8(2) 8.8(1.1) 108.5(18.5) 3.5(1.6) 
6 months 332 81.5(5.9) 13(1.9) 9.8(1) 111.9(17) 3.8(1) 
1 year 332 85.1(6.9) 13.4(1.5) 10(1.4) 112.8(17) 3.9(1.2) 
2 years 332 85.4(3.8) 13.5(1.8) 10.8(1.2) 112.9(16.5) 4(1.2) 
3 years 331 87.2(6.8) 13.9(1.3) 11.5(0.8) 113.8(16) 4.1(1.2) 
4 years 331 90.1(6.6) 14.3(1.9) 11.6(10) 114(16.5) 4(1.3) 
5 years 331 89.5(5.9) 14.3(1.6) 11.5(1) 115.8(16.6) 4.6(1) 
6 years 325 88.9(6.7) 14.1(2.9) 11.5(1) 117.4(16.8) 4.6(1.1) 
7 years 317 88.5(6.4) 14(3) 11.5(0.9) 116.5(16) 5.6(1) 
8 years 268 88.2(6.9) 14(2.4) 11.5(0.9) 116(15.9) 4.8(1.3) 
9 years 169 86.5(7.2) 14.2(3.1) 11.3(0.9) 115.8(15.4) 4.9(1.2) 
10 years 103 85.2(8.1) 13.6(2.9) 11(0.9) 116(15.6) 4.9(1.1) 
325 
Table 4. HSS-KS results by patellar resurfacing The numbers reported are mean (SD). The Mann-326 
Whitney test was used. 327 
 
Pre-operative Post-operative 
                       Resurfaced Not resurfaced p-value Resurfaced 
Not 
resurfaced p-value 
                       (N=163)           (N=169)           (N=46)            (N=151)            
Total Knee Score  54.8 (6.7) 54.4 (7.6) 0.91 87.2 (5.8) 85.4 (6.8) 0.03 
Pain  7.4 (2.5) 7.2 (2.5) 0.25 14.0 (2.0) 13.5 (2.3) 0.07 
Functional score 6.5(2.6) 6.4 (2.7) 0.88 10.9 (1.0) 10.9 (1.0) 0.95 
Range of movement 67.2 (8.7) 67.0 (9.0) 0.82 115.2(16.0) 113.4 (17.1) 0.17 
Pain at test 6.3(3.0) 6.2(3.3) 0.74 12.3(2.5) 12.3 (2.5) 0.99 
Stairs 2.2(0.8) 2.2(0.7) 0.86 4.4(1.2) 4.4 (1.2) 0.85 
 328 
329 
Table 5. HSS-KS results regarding the clinical evaluation of the patella. Numbers reported are 330 
percentage and absolute frequency. Test used: chi square. 331 
 
pre-operative post-operative 
             Replaced Not replaced 
p-value 
Replaced Not replaced 
p-value 
             (N=163) (N=169) (N=146) (N=159) 
Motility 
  
ns 
  
ns 
Absent 72% (110) 60% ( 99) 
 
7%(11) 9%(15) 
 Normal 26% ( 40) 40% ( 66) 
 
93% (141) 91% (150) 
 Hyper-
motility 1% (  2) 0% (  0) 
 
0%(0) 0%(0) 
 Pain 
  
<0.001 
  
ns 
Absent 18% ( 27) 37% ( 61) 
 
96%(146) 88%(146) 
 At rest 12% ( 18) 13% ( 21) 
 
4% (  6) 12% ( 19) 
 Standing 70% (107) 50% ( 83) 
    Crepitus 
  
ns 
  
<0.001 
Absent 12% (19) 25% (42) 
 
98%(149) 72% (119) 
 Present 88% (133)     75% (123) 2% (  3) 28% ( 46) 
   332 
333 
Table 6. Results of the radiographic evaluation in terms of component alignment, according to the 334 
Knee Society Roentgenographic Evaluation System (KS-RES) and incidence and location of the 335 
radiolucent lines. 336 
 337 
 338 
 339 
 340 
Parameter N Final follow-up  
Femoral components position, degrees   
   Antero-posterior view  96.56 (1.77) 
   Sagittal view  3.57 (2.61) 
Tibial components position, degrees   
   Antero-posterior view  88.18 (2.82) 
   Sagittal view  88.37 (2.53) 
   
Total radiolucent lines 157 157 lines in 65 knees 
   Progressive  3% (4) 
   Non Progressive  98% (153) 
   
Radiolucent lines divides for zones   
   Tibial antero-posterior 157 31% (49) 
     Principal zone: 6 49 27% (13) 
   Tibial lateral 157 32% (50) 
     Principal zone: 3 50 50% (25) 
   Femoral 157 37% (58) 
     Principal zone: 1 58 45% (26) 
